China Shineway Pharmaceutical Group Limited

SZSC:2877 Stock Report

Market Cap: HK$6.4b

China Shineway Pharmaceutical Group Future Growth

Future criteria checks 2/6

China Shineway Pharmaceutical Group is forecast to grow earnings and revenue by 8.3% and 12.8% per annum respectively. EPS is expected to grow by 7.5% per annum. Return on equity is forecast to be 14.7% in 3 years.

Key information

8.3%

Earnings growth rate

7.5%

EPS growth rate

Pharmaceuticals earnings growth11.7%
Revenue growth rate12.8%
Future return on equity14.7%
Analyst coverage

Low

Last updated13 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

SZSC:2877 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20265,7031,3391,3231,4223
12/31/20254,9251,1807859723
12/31/20244,3261,0878771,1893
6/30/20244,2051,1051,0721,175N/A
3/31/20244,3611,0379301,054N/A
12/31/20234,517970788933N/A
9/30/20234,525926795957N/A
6/30/20234,534883801982N/A
3/31/20234,2428038911,046N/A
12/31/20223,9517239801,110N/A
9/30/20223,718651814941N/A
6/30/20223,485579648772N/A
3/31/20223,354568629738N/A
12/31/20213,224557610703N/A
9/30/20213,122453609690N/A
6/30/20213,020350608677N/A
3/31/20212,838322590658N/A
12/31/20202,656295573639N/A
9/30/20202,592382485561N/A
6/30/20202,528469397483N/A
3/31/20202,617486337426N/A
12/31/20192,706503277368N/A
9/30/20192,670520289382N/A
6/30/20192,633537301396N/A
3/31/20192,602521347465N/A
12/31/20182,570506393533N/A
9/30/20182,492516390521N/A
6/30/20182,413526388509N/A
3/31/20182,166489N/A500N/A
12/31/20171,920452N/A491N/A
9/30/20171,897474N/A588N/A
6/30/20171,873496N/A685N/A
3/31/20171,933542N/A709N/A
12/31/20161,993589N/A734N/A
9/30/20161,935569N/A709N/A
6/30/20161,877549N/A685N/A
3/31/20161,966603N/A715N/A
12/31/20152,055658N/A745N/A
9/30/20152,147672N/A723N/A
6/30/20152,239685N/A701N/A
3/31/20152,234695N/A737N/A
12/31/20142,229705N/A773N/A
9/30/20142,228704N/A740N/A
6/30/20142,227703N/A706N/A
3/31/20142,207693N/A613N/A
12/31/20132,187684N/A520N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 2877's forecast earnings growth (8.3% per year) is above the savings rate (2.3%).

Earnings vs Market: 2877's earnings (8.3% per year) are forecast to grow slower than the Hong Kong market (11.5% per year).

High Growth Earnings: 2877's earnings are forecast to grow, but not significantly.

Revenue vs Market: 2877's revenue (12.8% per year) is forecast to grow faster than the Hong Kong market (7.8% per year).

High Growth Revenue: 2877's revenue (12.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 2877's Return on Equity is forecast to be low in 3 years time (14.7%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y